- Novavax (NASDAQ:NVAX) prices its public offering of 24,137,931 shares of common stock at $7.25 per share. Underwriters over-allotment is an additional 3,620,689 shares. Closing date is March 31.
- Net proceeds of ~$165M will fund the advancement of the company's lead vaccine candidates, other research programs and general corporate purposes.
- Previously: Novavax initiates equity offering (March 24)
Novavax prices equity offering
Recommended For You
About NVAX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| NVAX | - | - |
| Novavax, Inc. | ||